Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.3
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Collaboration revenue $ 147,805 $ 349,943
Operating expenses:    
Research and development 11,814,690 21,444,019
General and administrative 7,125,732 8,575,283
Total operating expense 18,940,422 30,019,302
Loss from operations (18,792,617) (29,669,359)
Foreign exchange loss (40,077) (52,482)
Net loss $ (18,832,694) $ (29,721,841)
Per share information:    
Net loss per share, basic $ (18.14) $ (150.52)
Net loss per share, diluted $ (18.14) $ (150.52)
Weighted average shares outstanding, basic 1,038,188 197,462
Weighted average shares outstanding, diluted 1,038,188 197,462